{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:31:39Z","timestamp":1790494299060,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"H\u00f4pitaux Champagne Sud"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3652-2","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T08:17:47Z","timestamp":1542010667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Factors influencing the use of the \u201cnot for generic substitution\u201d mention for prescriptions in primary care: a survey with general practitioners"],"prefix":"10.1186","volume":"18","author":[{"given":"Virgil","family":"Beauvais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Marque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Fert\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Chrusciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Souille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Nazeyrollas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0925-6948","authenticated-orcid":false,"given":"St\u00e9phane","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"3652_CR1","volume-title":"Les comptes nationaux de la sant\u00e9 2012","author":"M-A Le Garrec","year":"2013","unstructured":"Le Garrec M-A, Bouvais M. Les comptes nationaux de la sant\u00e9 2012. DREES; 2013."},{"key":"3652_CR2","volume-title":"Guideline on the investigation of bioequivalence","author":"Committee for Medicinal Products for Human Use","year":"2010","unstructured":"Committee for Medicinal Products for Human Use. Guideline on the investigation of bioequivalence. 2010."},{"key":"3652_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.22452","volume":"70","author":"GL Krauss","year":"2011","unstructured":"Krauss GL, Caffo B, Chang Y-T, Hendrix CW, Chuang K. Assessing bioequivalence of generic antiepilepsy drugs. Ann Neurol. 2011;70:221\u20138.","journal-title":"Ann Neurol"},{"key":"3652_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1528-1167.2007.01007.x","volume":"48","author":"F Andermann","year":"2007","unstructured":"Andermann F, Duh MS, Gosselin A, Paradis PE. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia. 2007;48:464\u20139.","journal-title":"Epilepsia"},{"key":"3652_CR5","volume-title":"Rapport 2012 sur les m\u00e9dicaments g\u00e9n\u00e9riques","author":"Mutualit\u00e9 Fran\u00e7aise","year":"2012","unstructured":"Mutualit\u00e9 Fran\u00e7aise. Rapport 2012 sur les m\u00e9dicaments g\u00e9n\u00e9riques. 2012."},{"key":"3652_CR6","volume-title":"Rapport sur l\u2019application des lois de financement de la s\u00e9curit\u00e9 sociale. La Documentation fran\u00e7aise","author":"Cour des comptes","year":"2014","unstructured":"Cour des comptes. La diffusion des m\u00e9dicaments g\u00e9n\u00e9riques\u00a0: des r\u00e9sultats trop modestes, des co\u00fbts \u00e9lev\u00e9s. In: Rapport sur l\u2019application des lois de financement de la s\u00e9curit\u00e9 sociale. La Documentation fran\u00e7aise; 2014."},{"key":"3652_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/1468-0009.12279","volume":"95","author":"OJ Wouters","year":"2017","unstructured":"Wouters OJ, Kanavos PG, McKEE M. Comparing generic drug Markets in Europe and the United States: prices, volumes, and spending. Milbank Q. 2017;95:554\u2013601.","journal-title":"Milbank Q"},{"key":"3652_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MLR.0b013e31818af850","volume":"47","author":"WH Shrank","year":"2009","unstructured":"Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009;47:319\u201325.","journal-title":"Med Care"},{"key":"3652_CR9","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/S0149-2918(03)80340-5","volume":"25","author":"P Meredith","year":"2003","unstructured":"Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25:2875\u201390.","journal-title":"Clin Ther"},{"key":"3652_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(07)70105-9","volume":"6","author":"DC Heaney","year":"2007","unstructured":"Heaney DC, Sander JW. Antiepileptic drugs: generic versus branded treatments. Lancet Neurol. 2007;6:465\u20138.","journal-title":"Lancet Neurol"},{"key":"3652_CR11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.healthpol.2015.09.007","volume":"119","author":"LN Skaltsas","year":"2015","unstructured":"Skaltsas LN, Vasileiou KZ. Patients\u2019 perceptions of generic drugs in Greece. Health Policy Amst Neth. 2015;119:1406\u201314.","journal-title":"Health Policy Amst Neth."},{"key":"3652_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1377\/hlthaff.28.2.546","volume":"28","author":"WH Shrank","year":"2009","unstructured":"Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients\u2019 perceptions of generic medications. Health Aff Proj Hope. 2009;28:546\u201356.","journal-title":"Health Aff Proj Hope"},{"key":"3652_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.sapharm.2015.03.003","volume":"12","author":"Predictors of generic substitution","year":"2016","unstructured":"Predictors of generic substitution. The role of psychological, sociodemographic, and contextual factors. Res Soc Adm Pharm. 2016;12:119\u201329.","journal-title":"Res Soc Adm Pharm"},{"key":"3652_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.healthpol.2010.08.002","volume":"99","author":"CP Chong","year":"2011","unstructured":"Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy Amst Neth. 2011;99:139\u201348.","journal-title":"Health Policy Amst Neth"},{"key":"3652_CR15","unstructured":"A review of patient perspectives on generics substitution - GaBI Journal \n                    http:\/\/gabi-journal.net\/a-review-of-patient-perspectives-on-generics-substitution-what-are-the-challenges-for-optimal-drug-use.html\n                    \n                  . Accessed 1 Jan 2018."},{"key":"3652_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.healthpol.2011.10.001","volume":"104","author":"C Quintal","year":"2012","unstructured":"Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy Amst Neth. 2012;104:61\u20138.","journal-title":"Health Policy Amst Neth."},{"key":"3652_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.healthpol.2010.07.006","volume":"99","author":"Patients\u2019 attitudes towards generic drug substitution in Japan","year":"2011","unstructured":"Patients\u2019 attitudes towards generic drug substitution in Japan. Health Policy. 2011;99:60\u20135.","journal-title":"Health Policy"},{"key":"3652_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/postgradmedj-2012-131730","volume":"89","author":"K Faasse","year":"2013","unstructured":"Faasse K, Petrie KJ. The nocebo effect: patient expectations and medication side effects. Postgrad Med J. 2013;89:540\u20136.","journal-title":"Postgrad Med J"},{"key":"3652_CR19","first-page":"1138","volume":"20","author":"SS Dunne","year":"2014","unstructured":"Dunne SS, Shannon B, Cullen W, Dunne CP. Perceptions and attitudes of community pharmacists towards generic medicines. J Manag Care Spec Pharm. 2014;20:1138\u201346.","journal-title":"J Manag Care Spec Pharm"},{"key":"3652_CR20","volume-title":"La d\u00e9mographie m\u00e9dicale en r\u00e9gion Champagne-Ardenne. Situation en 2013","author":"G Le Breton-Lerouvillois","year":"2013","unstructured":"Le Breton-Lerouvillois G. La d\u00e9mographie m\u00e9dicale en r\u00e9gion Champagne-Ardenne. Situation en 2013. 2013. \n                    https:\/\/www.conseil-national.medecin.fr\/sites\/default\/files\/champagne_ardenne_2013.pdf\n                    \n                  . Accessed 13 Jul 2018."},{"key":"3652_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.respe.2007.01.026","volume":"55","author":"A Sarradon-Eck","year":"2007","unstructured":"Sarradon-Eck A, Blanc M-A, Faure M. Users sceptical about generic drugs: an anthropological approach. Rev Epidemiol Sante Publique. 2007;55:179\u201385.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"11","key":"3652_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.revmed.2017.11.009","volume":"39","author":"S. Iskounen","year":"2018","unstructured":"Iskounen S, Simoneau G, Mouly S. Prospective study of the factors associated with the acceptance of generics substitution by patients and their liberal doctors. [Article in French] Rev Med Interne. 2018;39(11):849\u201354. \n                    https:\/\/doi.org\/10.1016\/j.revmed.2017.11.009\n                    \n                  . Epub 2017 Dec 28.","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"3652_CR23","doi-asserted-by":"publisher","first-page":"k714","DOI":"10.1136\/bmj.k714","volume":"360","author":"B Casassus","year":"2018","unstructured":"Casassus B. Risks of reformulation: French patients complain after Merck modifies levothyroxine pills. BMJ. 2018;360:k714.","journal-title":"BMJ"},{"key":"3652_CR24","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00228-013-1539-z","volume":"69","author":"J Rathe","year":"2013","unstructured":"Rathe J, Larsen P, Andersen M, Paulsen M, Jarb\u00f8l D, Thomsen J, et al. Associations between generic substitution and patients\u2019 attitudes, beliefs and experiences. Eur J Clin Pharmacol. 2013;69:1827\u201336.","journal-title":"Eur J Clin Pharmacol"},{"key":"3652_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jamia\/ocv192","volume":"23","author":"S Malhotra","year":"2016","unstructured":"Malhotra S, Cheriff AD, Gossey JT, Cole CL, Kaushal R, Ancker JS. Effects of an e-prescribing interface redesign on rates of generic drug prescribing: exploiting default options. J Am Med Inform Assoc JAMIA. 2016;23:891\u20138.","journal-title":"J Am Med Inform Assoc JAMIA"},{"key":"3652_CR26","first-page":"95","volume":"49","author":"A Boissel","year":"2014","unstructured":"Boissel A, Fagnoni P, Guignard M-H, Lazzarotti A, De Messi\u00e8res S, Sgro C. \u00c9valuation des bonnes pratiques de prescription de sortie en CHU : quels enjeux pour les traitements chroniques non substituables ? Pharm Hosp Clin. 2014;49:95\u2013101.","journal-title":"Pharm Hosp Clin"},{"key":"3652_CR27","first-page":"13","volume":"12","author":"H Michelon","year":"2014","unstructured":"Michelon H, Marcel J, Coudert M, Juillard K, Pochat L, Fernandez C, et al. Generic drugs at hospital discharge: assessment in geriatrics. Geriatr Psychol Neuropsychiatr Vieil. 2014;12:13\u20139.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"3652_CR28","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1365-2753.2011.01684.x","volume":"18","author":"W Spiegel","year":"2012","unstructured":"Spiegel W, Mlczoch-Czerny M-T, Jens R, Dowrick C. Quality circles for pharmacotherapy to modify general practitioners\u2019 prescribing behaviour for generic drugs. J Eval Clin Pract. 2012;18:828\u201334.","journal-title":"J Eval Clin Pract"},{"key":"3652_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S1474-4422(16)00014-4","volume":"15","author":"MD Privitera","year":"2016","unstructured":"Privitera MD, Welty TE, Gidal BE, Diaz FJ, Krebill R, Szaflarski JP, et al. Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial. Lancet Neurol. 2016;15:365\u201372.","journal-title":"Lancet Neurol"},{"key":"3652_CR30","unstructured":"Rault J. La d\u00e9mographie m\u00e9dicale en r\u00e9gion Champagne-Ardenne: Situation en 2015: Conseil National de l\u2019Ordre des M\u00e9decins; 2015. \n                    https:\/\/www.conseil-national.medecin.fr\/sites\/default\/files\/atlas_national_de_la_demographie_medicale_2015.pdf\n                    \n                  . Accessed 01 Nov 2018."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3652-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T19:12:27Z","timestamp":1573499547000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3652-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3652"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3652-2","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"30 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was based on data from a unique questionnaire sent to physicians, therefore ethics approval was waived in conformity with existing national regulations (French Public Health Code 88\u2013138, December 20, 1988 and French Public Health Code 2004\u2013806, August 9, 2004). Due to the nature of the study (physician survey), written consent was not necessary (French Public Health Code 88\u2013138, December 20, 1988 and French Public Health Code 2004\u2013806, August 9, 2004).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"850"}}